Search PubMed⌕ Search

Biomedical subjects

J L Barron

Publications and source records attributed to J L Barron.

61 records · Page 4Linked to original sources

A radio-immunoassay of 17-alpha-hydroxyprogesterone.

A method is described for the determination of 17 alpha-hydroxyprogesterone (17-OHP) in plasma. Antisera were raised in rabbits against 11-deoxycortisol-21-hemisuccinate-bovine serum albumin (11-DOC-21-HS-BSA) and 17 alpha-hydroxyprogesterone-3-carboxymethyloxime-bovine serum albumin (17-OHP-3-CMO-BSA). An antiserum to 11-DOC-21-HS-BSA exhibited cross-reaction with progesterone (29%), 11-deoxycortisol (100%), cortisol (17%) and testosterone (10%) and was therefore not appropriate for quantitation of 17-OHP in plasma. An antiserum to 17-OHP-3-CMO-BSA cross-reacted with progesterone (9,7%), 11-deoxycortisol (50%) and less than 1% with all other major naturally occurring steroid hormones. A radio-immunoassay (RIA) was developed using the antiserum to 17-OHP-4-CMO-BSA. The intra-assay and interassay coefficients of variation were 7,2% and 10,5% respectively. The normal ranges (nmol/l plasma) of samples extracted with hexane:benzene (1:1) and purified by Sephadex LH-20 chromatography were 0,28-4,7 for men, 0,84-3,0 for women (follicular phase), 3,0-11,0 for women (luteal phase), 4,6-22,1 for pregnant women, 18,5-123,9 for cord blood, 0,12-5,0 for children and 56,3-1 032 for persons with congenital adrenal hyperplasia (CAH) due to a 21-hydroxylation enzyme defect. Sephadex LH-20 purification of plasma extracts could be omitted when using the RIA as a screening procedure for CAH due to a 21-hydroxylation enzyme defect.

Adult↗

Gas-liquid chromatographic analysis of urinary steroids.

A method for gas-liquid chromatographic separation and quantitation of urinary steroid metabolites is described. A normal reference range has been established and classic examples of urinary steroid profiles of the major steroid disorders are given.

17-Ketosteroids↗

Memory deficits associated with chronic fatigue immune dysfunction syndrome.

Performance on tests of memory in 39 patients who met Center for Disease Control (CDC) criteria for chronic fatigue immune dysfunction syndrome (CFIDS) was compared with 23 depressed patients (DSM-III-R) and 129 healthy controls. Although the CFIDS patients had normal neuropsychological profiles, they significantly overestimated their ability (metamemory), performed significantly worse on tests of recall as context increased (e.g., recognition), made more errors when rehearsal was prevented, and had delayed mental scanning as memory load increased. The overall pattern indicated that CFIDS patients had a significant memory deficit, far worse than implied by CDC criteria. The pattern for CFIDS patients was consistent with temporal-limbic dysfunction and significantly different than depressed patients and control subjects.

Adult↗

Growth hormone responses to growth hormone-releasing hormone (1-29)-NH2 and a D-Ala2 analog in normal men.

Synthetic analogs of growth hormone-releasing hormone, GHRH(1-29)-NH2 and D-Ala2 GHRH(1-29)-NH2 were administered as a bolus intravenous injection to five normal men in a dose range of 0.015 to 0.5 micrograms/kg body weight. Vehicle only was administered in a control study. Peak responses to GHRH analogs occurred at 15 or 30 min. An increase in the integrated plasma growth hormone (GH) response was observed at each dose. The dose-response curve of GHRH(1-29)-NH2 indicated that it has a similar molar potency to GHRH(1-40) and GHRH(1-44). The potency of D-Ala2 GHRH(1-29)-NH2 was approximately twice that of GHRH(1-29)-NH2. Neither analog affected blood levels of PRL, TSH, LH, FSH, ACTH, insulin, glucagon, glucose, cortisol, free thyroxine, and free triiodothyronine. No side effects were noted other than transient flushing with the highest dose administered. The findings demonstrate GHRH(1-29)-NH2 and its D-Ala2 analog are potent stimulators of GH release and have potential application in clinical medicine.

Adult↗